Please ensure Javascript is enabled for purposes of website accessibility

pharmaceuticals

May 13, 2020

Richmond pharmaceutical company expands into Canada

Richmond-based pharmaceutical company Kaléo announced Wednesday it is expanding its market to Canada, offering its epinephrine auto-injector Allerject. The product used to treat severe allergic reactions will be available in pharmacies across Canada starting May 19.  In response to a shortage of EpiPen in Canada in 2018, Kaléo’s original epinephrine auto-injector Auvi-Q was available in [[...]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.